ABOUT SYROSINGOPINE

Proteolysis Targeting Chimera (PROTAC) technological innovation is often a rapidly emerging choice therapeutic strategy With all the potential to address most of the troubles presently confronted in fashionable drug enhancement applications. PROTAC engineering employs smaller molecules that recruit target proteins for ubiquitination and removal thr